Thomas Helbich

641 total citations
18 papers, 452 citations indexed

About

Thomas Helbich is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Helbich has authored 18 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Helbich's work include Radiomics and Machine Learning in Medical Imaging (3 papers), MRI in cancer diagnosis (3 papers) and Breast Lesions and Carcinomas (3 papers). Thomas Helbich is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (3 papers), MRI in cancer diagnosis (3 papers) and Breast Lesions and Carcinomas (3 papers). Thomas Helbich collaborates with scholars based in Austria, Germany and Denmark. Thomas Helbich's co-authors include Mathew Wallis, I. Schreer, Johannes Dimopoulos, Gregor Goldner, Daniel Berger, Richard Pötter, Stefan Lang, Guenther G. Steger, B Steiner and R. Jakesz and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Journal of Hepatology.

In The Last Decade

Thomas Helbich

17 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Helbich Austria 9 136 115 93 92 92 18 452
Viorel Scripcariu Romania 10 44 0.3× 191 1.7× 41 0.4× 72 0.8× 119 1.3× 63 658
Cam Nguyen United States 14 119 0.9× 169 1.5× 35 0.4× 84 0.9× 95 1.0× 42 602
Tarık Esen Türkiye 18 185 1.4× 156 1.4× 65 0.7× 27 0.3× 751 8.2× 85 1.0k
Lütfi Doğan Türkiye 13 59 0.4× 329 2.9× 58 0.6× 127 1.4× 52 0.6× 86 689
Marie Bannier France 17 56 0.4× 533 4.6× 236 2.5× 116 1.3× 67 0.7× 62 850
G Aliberti Italy 13 120 0.9× 121 1.1× 74 0.8× 43 0.5× 96 1.0× 51 664
Κonstantinos Romanidis Greece 13 38 0.3× 175 1.5× 17 0.2× 45 0.5× 164 1.8× 55 594
Yu Min China 14 54 0.4× 125 1.1× 29 0.3× 32 0.3× 68 0.7× 49 519
Steffi Hartmann Germany 15 116 0.9× 272 2.4× 71 0.8× 356 3.9× 48 0.5× 43 746
M. Berman United States 8 135 1.0× 102 0.9× 94 1.0× 92 1.0× 134 1.5× 19 582

Countries citing papers authored by Thomas Helbich

Since Specialization
Citations

This map shows the geographic impact of Thomas Helbich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Helbich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Helbich more than expected).

Fields of papers citing papers by Thomas Helbich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Helbich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Helbich. The network helps show where Thomas Helbich may publish in the future.

Co-authorship network of co-authors of Thomas Helbich

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Helbich. A scholar is included among the top collaborators of Thomas Helbich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Helbich. Thomas Helbich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Woitek, Ramona, Daniela Prayer, Azadeh Hojreh, & Thomas Helbich. (2016). Radiological staging in pregnant patients with cancer. ESMO Open. 1(1). e000017–e000017. 17 indexed citations
3.
Pinker, Katja, Pascal Baltzer, H. Magometschnigg, et al.. (2015). PET/MRI in cervical cancer: Insights into tumor biology.. Journal of Clinical Oncology. 33(15_suppl). 5597–5597. 2 indexed citations
5.
Bickel, Hubert, et al.. (2012). 107 Diffusion Weighted MRI as a Biomarker for Breast Cancer Malignancy. European Journal of Cancer. 48. S72–S72. 2 indexed citations
6.
Spick, Claudio, et al.. (2011). Negativer Vorhersagewert der MR-Mammographie (MRM) bei MRM BI-RADS™ 3 klassifizierten Läsionen.. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 183(S 01).
7.
Helbich, Thomas, et al.. (2008). Kosteneinsparungspotenzial der Nadelbiopsie im Vergleich zur offenen Biopsie bei der Diagnose suspekter, nichtpalpabler Brustläsionen: Metaanalyse der Literatur und Vergleich mit Daten aus dem deutschen Sprachraum. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 180(2). 134–142. 17 indexed citations
8.
Wallis, Mathew, et al.. (2006). Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. European Radiology. 17(2). 581–588. 93 indexed citations
9.
Dimopoulos, Johannes, Daniel Berger, Stefan Lang, et al.. (2006). Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. International Journal of Radiation Oncology*Biology*Physics. 64(5). 1380–1388. 100 indexed citations
10.
Schueller, Gerd, et al.. (2004). Bronchial reactivity in hyperresponsive patients and healthy individuals: demonstration with high resolution computed tomography. European Journal of Radiology. 52(2). 151–156. 8 indexed citations
11.
Bloch, B, Thomas Helbich, & Gertraud Heinz‐Peer. (2002). [Prostatic carcinoma: current status of diagnostic imaging].. PubMed. 89–91. 1 indexed citations
12.
Partik, B., R. Mallek, M. Rudas, et al.. (2001). Maligne und benigne Erkrankungen der Brust bei 41 männlichen Patienten: Mammographie und Sonographie mit histopathologischer Korrelation. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 173(11). 1012–1018. 8 indexed citations
13.
Staudenherz, Anton, Claudette Abela, Bruno Niederle, et al.. (1997). Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. European Journal of Nuclear Medicine and Molecular Imaging. 24(2). 143–149. 70 indexed citations
14.
Kohlberger, Petra, Thomas Helbich, & Andrea Schaller. (1997). [Delivery following surgically treated sacrococcygeal teratoma in the mother].. PubMed. 201(4). 148–51. 2 indexed citations
15.
Müller, Markus, Robert M. Mader, B Steiner, et al.. (1997). 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients.. PubMed. 57(13). 2598–601. 75 indexed citations
16.
Trattnig, Siegfried, M. Breitenseher, J O Haller, et al.. (1995). [Tarsal tunnel syndrome. MRI diagnosis].. PubMed. 35(7). 468–72. 4 indexed citations
17.
Kainberger, F., Thomas Helbich, S. Youssefzadeh, et al.. (1995). [Ultrasound diagnosis of the popliteal fossa].. PubMed. 35(2). 125–33. 6 indexed citations
18.
Thalhammer, Florian, Heinz Gisslinger, Andreas Chott, et al.. (1994). Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia. Annals of Hematology. 68(2). 97–99. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026